Older Amyloid Beta as a Candidate Blood Biomarker of Early Cognitive Decline in the Elderly—A Preliminary Study
(1) Background/Objectives: The pathogenic process of Alzheimer’s disease (AD) is known to begin decades before its clinical onset. This period, although imperceptible to the patient, encompasses a gradual neuronal loss. The first symptoms of dementia, often classified as mild cognitive impairment (M...
Saved in:
| Main Authors: | Oliwia McFarlane, Mariusz Kozakiewicz, Kornelia Kędziora-Kornatowska, Anita Gałęska-Śliwka, Milena Wojciechowska |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Current Issues in Molecular Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1467-3045/47/3/203 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring apathy components and their relationship in cognitive decline: insights from a network cross-sectional study
by: Pierfrancesco Sarti, et al.
Published: (2025-02-01) -
Plasma biomarkers of amyloid, tau, astrogliosis, and axonal injury in a mixed memory clinic cohort
by: Helena Sophia Gleerup, et al.
Published: (2025-01-01) -
Cognitive performance classification of older patients using machine learning and electronic medical records
by: Monika Richter-Laskowska, et al.
Published: (2025-02-01) -
Comparative Assessments of PET and ASL MR Perfusion in the Evaluation of Early Dementia
by: Savyasachi Jain, et al.
Published: (2025-02-01) -
Construction Tasks in Diagnosis of Early Cognitive Impairment – A Critical Revisitation
by: Sayooja Sachithanandan, et al.
Published: (2025-05-01)